1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Acne Drugs Market 2016-2020

Global Acne Drugs Market 2016-2020

  • November 2015
  • -
  • Infiniti Research Limited
  • -
  • 83 pages

Global Acne Drugs Market 2016-2020
Covering: This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC). It outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Allergan, Galderma, Stiefel, and Valeant.
Market outlook of acne drugs
Technavio’s market research analyst predicts the global acne drugs market to grow steadily at a CAGR of approximately 3% during the forecast period. The occurrence of acne due to lifestyle changes is the primary driver for the market. Sedentary lifestyle and unhealthy food habits lead to hormonal problems, which trigger the development of acne. Lack of sleep, emotional and work-related stress, smoking, drug abuse, and alcohol consumption are major triggers for the occurrence of acne among teenagers and adults.
The rise in disposable income has encouraged consumers, especially the middle-class income group, to spend more on personal care products. The rising awareness of acne and the current and upcoming treatments is expected to drive the acne drugs market through the forecast period. Women particularly, play a crucial role in this market as the demand generated by them influences the market growth considerably.
Segmentation by drug class and analysis of the acne drugs market
- Antibiotics
- Anti-inflammatory drugs
- Antimicrobial
- Combination medications
- Hormonal agents
- Oral retinoid
- Topical retinoid
Acne medication depends on the skin type and the severity of the condition. For instance, oral retinoid agents are considered as the appropriate treatment for severe acne. These drugs help prevent excessive oil production, bacterial acne growth, and inflammation.
Segmentation by method of administration and analysis of the acne drugs market
- Topical
- Oral
The topical drugs segment dominated the market during 2015, accounting for a market share of around 54%. Ease of application, low systemic side-effects, and easy availability of these products are the primary drivers for the growth of this segment.
Segmentation by type and analysis of the acne drugs market
- Prescription drugs
- OTC drugs
Prescription drugs dominated the market during 2015 due to the increased awareness about acne and the treatments options, especially in the developed countries. For instance, Epiduo, Benzaclin, and Duac are some of the popular acne prescription drugs available in the market.
Segmentation by geography and analysis of the acne drugs market
- Americas
- APAC
- EMEA
The Americas accounted for around 90% of the market share during 2015 but is expected to witness a decline in sales during the forecast period. Lifestyle changes, increase in awareness programs about acne, and availability of acne treatment options are the primary drivers for market growth in this region.
Competitive landscape and key vendors
The global acne drugs market is dominated by key vendors. The availability of OTC drugs and the preference for alternative therapies for treating acne has been restricting the sales of branded acne products. Vendors in this market are anticipated to invest heavily on R&D during the forecast period.
The leading vendors in the market are -
- Allergan
- Galderma
- Stiefel
- Valeant
The other prominent vendors in the market include AndroScience, Anterios, Aqua Pharmaceuticals, Astellas, Bayer HealthCare, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, COSMO Pharmaceuticals, Dermira, Elorac, F.Hoffmann-La Roche, Foamix, GlaxoSmithKline, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Johnson & Johnson, Meda, Mylan, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Promius Pharma, Ranbaxy, Reckitt Benckiser, Skinvisible Pharmaceuticals, Teva, Versapharm, and XBiotech.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global acne drugs market?
- What are the key market trends impacting the growth of the acne drugs market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the vendors in the global acne drugs market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the acne drugs market?
Technavio also offers customization on reports based on specific client requirement.

Related reports:
- Global Shaving Lotions and Creams Market 2015-2019
- Global Dermatology Diagnostic Devices Market- Industry Analysis 2015-2019
- Global Energy-based Therapeutics Market - Industry Analysis 2015-2019

Table Of Contents

Global Acne Drugs Market 2016-2020
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Acne: An overview
Understanding the disease
Pathophysiology
Causes
Types of acne
Implications of acne
Management
Epidemiology
PART 06: Pipeline analysis
Sarecycline
IDP-121
CB-03-01
IDP-120
CB-06-04
ASC-J9
Visonac
DRM-01
FMX101
True human antibody RA-18C3
SB204
Acebilustat
ANT-1207
PART 07: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 08: Reimbursement scenario for acne drugs
PART 09: Market segmentation by drug class
Antibiotics
Anti-inflammatory drugs
Antimicrobials
Combination drugs
Hormonal agents
Oral retinoids
Topical retinoids
PART 10: Market segmentation by route of administration
Topical
Oral
PART 11: Market segmentation by type
Prescription drugs
OTC drugs
PART 12: Global acne drugs market: OTC drugs
Major acne OTC products
Adverse effects of OTC acne drugs
Major vendors of OTC acne drugs
OTC acne drugs market in Europe
PART 13: Geographical segmentation
Acne drugs market in Americas
Global acne drugs market in EMEA
Acne drugs market in APAC
PART 14: Market drivers
Prevalence of acne
Lifestyle changes
Significant unmet medical needs
Promising drug pipeline
Rise in disposable income
PART 15: Impact of drivers
PART 16: Market challenges
Adverse effects of drugs
Poor patient adherence
Preference for alternative therapies
Intense market competition
PART 17: Impact of drivers and challenges
PART 18: Market trends
Preference for combination therapies
Acne awareness programs
Product innovations
Increased use of OTC products over prescription drugs
Marketing of OTC acne products
PART 19: Vendor landscape
Competitive scenario
Market share analysis 2015
Valeant Pharmaceuticals
Galderma
Allergan
Stiefel Laboratories
Other prominent vendors
PART 20: Appendix
List of abbreviations
PART 21: Explore Technavio

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Acne drugs: Key buying criteria
Exhibit 03: Types of acne based on severity
Exhibit 04: Types of acne based on severity of inflammation
Exhibit 05: Implications of acne
Exhibit 06: Treatment algorithm: Management of acne
Exhibit 07: Acne drugs: Pipeline portfolio
Exhibit 08: Global acne drugs market 2015-2020 ($ millions)
Exhibit 09: Five forces analysis
Exhibit 10: Oral prescription acne drugs: Reimbursement by payers in US 2014
Exhibit 11: Topical prescription acne drugs: Reimbursement by payers in US 2014
Exhibit 12: Global acne drugs market segmentation by drug class
Exhibit 13: Global acne drugs market segmentation by route of administration
Exhibit 14: Global acne drugs market segmentation by route of administration 2015
Exhibit 15: Revenue of topical prescription drugs in US 2015
Exhibit 16: Revenue of oral prescription drugs in US 2015
Exhibit 17: Global acne drugs market segmentation by type
Exhibit 18: Global acne drugs market segmentation by type 2015
Exhibit 19: OTC drugs: Advantages and disadvantages
Exhibit 20: AcneFree by Valeant Pharmaceuticals: SWOT analysis
Exhibit 21: Clearasil by Reckitt Benckiser: SWOT analysis
Exhibit 22: Clean and Clear by Johnson and Johnson: SWOT analysis
Exhibit 23: Neutrogena by Johnson and Johnson: SWOT analysis
Exhibit 24: Proactiv by Guthy-Renker: SWOT analysis
Exhibit 25: Global acne drugs market segmentation by geography 2015
Exhibit 26: Global acne drugs market segmentation by geography 2015-2020 ($ millions)
Exhibit 27: Acne drugs market in Americas 2015-2020 ($ millions)
Exhibit 28: Acne drugs market in US 2015-2020 ($ millions)
Exhibit 29: Acne drugs market in EMEA 2015-2020 ($ millions)
Exhibit 30: Acne drugs market in APAC 2015-2020 ($ millions)
Exhibit 31: Impact of drivers
Exhibit 32: Impact of drivers and challenges
Exhibit 33: Ranking of leading vendors 2015
Exhibit 34: Valeant Pharmaceuticals: Business segmentation by revenue 2014
Exhibit 35: Valeant Pharmaceuticals: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: Valeant Pharmaceuticals: Product segmentation by revenue 2014
Exhibit 37: Valeant Pharmaceuticals: Geographical segmentation by revenue 2014
Exhibit 38: Valeant Pharmaceuticals: SWOT analysis
Exhibit 39: Galderma: Therapeutic categories
Exhibit 40: Galderma: SWOT analysis
Exhibit 41: Allergan: Business segmentation by product revenue 2014
Exhibit 42: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 43: Allergan: Geographical segmentation by revenue 2014
Exhibit 44: Allergan: SWOT analysis
Exhibit 45: Stiefel Laboratories: Product categories
Exhibit 46: Stiefel Laboratories: SWOT analysis

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.